A new publication involving MOTS-c appeared in the journal eLife on August 18, 2026. The paper is titled "MOTS-c is a mitochondrial-encoded interferon-linked host defense peptide." MOTS-c remains classified as an unapproved research compound. This entry reflects the publication record only, including its title, journal, and date. No findings, results, or conclusions from the study are being summarized here. The publication is indexed under PubMed ID 42611943 and can be reviewed directly through the linked source for full context. As with all research-stage compounds, MOTS-c has not received regulatory approval for any therapeutic use. Readers interested in the broader context of MOTS-c research, including its classification and general background, are encouraged to consult the compound overview for additional information.</body_markdown>
<parameter name="sources">["https://pubmed.ncbi.nlm.nih.gov/42611943/"]